Bristol-Myers Squibb Foundation

About Bristol-Myers Squibb Foundation

Bristol-myers Squibb Foundation Inc. shows a strong pattern of large institutional grants rather than broad small-ticket philanthropy. The largest recent awards in the file went to Medical College of Virginia, including $15,175,285 in 2025 and $9,094,944 in 2024, alongside another $3,075,000 payment in 2025. Texas Children’s Hospital also received multi-million-dollar support, with $7,500,000 in 2023 and $7,000,000 in 2025. That mix points to a funder that backs hospitals, research centers, and health systems through sizable general-support grants. The foundation’s stated programs reinforce that profile. Its portfolio includes competitive research grants, neuropsychiatry funding, pediatric cancers and blood disorders, a lung cancer control program, and the Robert A. Winn Diversity in Clinical Trials Award Program. A New Jersey safety-net initiative launched in 2023 also signals interest in healthcare delivery and capacity-building. Employee giving is part of the picture as well: Charities Aid Foundation of America received $8,048,827 in 2025 for an employee giving program. Across the recent grants list, the foundation appears to favor institutional partners that can absorb large grants and apply them to research, clinical care, or health-system needs.

What Bristol-Myers Squibb Foundation Funds

Medical research is a central theme. The foundation gave $1,205,261 in 2025 to the American Association for Cancer Research for general support, and $993,985 in 2024 to Case Western Reserve University for the same purpose. It also supported University-based and hospital-based research institutions through unrestricted grants tied to clinical and translational work. Cancer and blood-disorder care is another clear thread. Princeton Healthcare System received $1,000,000 in both 2024 and 2025 for general support, while Roswell Park Alliance Foundation received $1,157,718 in 2024 and $1,114,173 in 2023. The program list also includes pediatric cancers and blood disorders, with work described around Global HOPE, sickle cell, and beta-thalassemia initiatives. Health equity and access show up in the foundation’s named initiatives too. In 2024, it launched a $1.8 million health equity initiative spanning Brazil, India, Thailand, and the United Kingdom. The New Jersey Safety Net Innovation Program added another delivery-focused line of work for safety-net providers.

How Bristol-Myers Squibb Foundation Gives